Workflow
Chanhen(002895)
icon
Search documents
川恒股份:川恒股份业绩说明会、路演活动信息
2023-05-18 07:18
证券代码: 002895 证券简称:川恒股份 贵州川恒化工股份有限公司 投资者关系活动记录表 编号:2023-002 | 投资者关系活动 | □特定对象调研 □ 分析师会议 | | | | --- | --- | --- | --- | | 类别 | 媒体采访 业绩说明会 □ √ | | | | | 路演活动 □ 新闻发布会 □ | | | | | □ 现场参观 | | | | | □ 其他 (请文字说明其他活动内容) | | | | 参与单位名称及 | 投资者网上提问 | | | | 人员姓名 | | | | | 时间 | 2023 年 月 日 (周三) 下午 15:00~17:30 | 5 | 17 | | 地点 | 公司通过全景网"投资者关系互动平台"(https://ir.p5w.net) | | | | | 采用网络远程的方式召开业绩说明会 | | | | 上市公司接待人 | 1、董事长兼总经理吴海斌 | | | | 员姓名 | 2、董事兼财务负责人何永辉 | | | | | 3、董秘兼副总经理李建 | | | | | 投资者提出的问题及公司回复情况 | | | | | 公司就投资者在本次说明会中提 ...
川恒股份(002895) - 举办2022年度业绩说明会暨投资者集体接待日活动的公告
2023-05-07 08:24
Group 1: Event Details - The annual performance briefing and investor reception day will be held on May 17, 2023, from 15:30 to 17:00 [2] - The event will be conducted remotely via the internet [2] - Key personnel attending include the Chairman and General Manager, Board Secretary, and Financial Officer [2] Group 2: Investor Engagement - Investors can participate by logging into the designated webpage [2] - A question collection process will be conducted prior to the event, open until May 15, 2023 [2] - Investors are encouraged to submit questions through the "Guizhou Capital Market" WeChat account [2] Group 3: Company Assurance - The company and its board members guarantee the accuracy and completeness of the disclosed information [2] - There will be responses to commonly asked questions during the briefing [2]
川恒股份(002895) - 2023 Q1 - 季度财报
2023-04-20 16:00
Financial Performance - The company's operating revenue for Q1 2023 was ¥998,391,331.48, representing a 64.07% increase compared to ¥608,505,246.94 in the same period last year[22] - Net profit attributable to shareholders for Q1 2023 was ¥158,346,504.48, up 52.11% from ¥104,100,108.69 year-on-year[22] - Basic earnings per share for Q1 2023 increased to ¥0.3205, a rise of 50.26% from ¥0.2133 in the same quarter last year[22] - Total profit increased by 58.74% year-on-year, primarily due to the rise in operating profit[31] - Net profit for the current period was ¥160,414,856.52, compared to ¥106,340,991.80 in the previous period, reflecting an increase of approximately 51%[48] - The total comprehensive income attributable to the parent company was ¥160,419,522.36, compared to ¥106,324,684.06 in the previous period, reflecting an increase of about 51%[48] Cash Flow - The net cash flow from operating activities for Q1 2023 was -¥80,471,733.29, a significant decrease of 30,376.03% compared to ¥265,793.53 in the previous year[22] - The net cash flow from financing activities was CNY 688,290,703.78, compared to CNY 1,110,583,369.84 in the previous period, indicating a decrease of about 38%[51] - The total cash and cash equivalents at the end of Q1 2023 amounted to CNY 1,709,795,591.10, down from CNY 2,051,634,801.38 in the previous period, reflecting a decline of approximately 16.6%[51] - The net increase in cash and cash equivalents for Q1 2023 was CNY 220,294,076.97, compared to CNY 849,134,206.01 in the previous period, showing a significant decrease of about 74%[51] - The impact of exchange rate changes on cash and cash equivalents was a decrease of CNY 1,247,123.98 in Q1 2023, compared to a decrease of CNY 1,813,883.78 in the previous period[51] Assets and Liabilities - Total assets at the end of Q1 2023 amounted to ¥10,746,912,844.78, reflecting a 5.87% increase from ¥10,138,442,979.05 at the end of the previous year[22] - The total liabilities as of the end of Q1 2023 were ¥5,580,877,368.53, compared to ¥5,187,998,507.62 at the end of the previous year[22] - Shareholders' equity attributable to the parent company reached ¥4,560,624,296.72, up 4.14% from ¥4,378,478,346.68 year-on-year[22] - The company recorded a total equity of ¥5,166,035,476.25 at the end of Q1 2023, up from ¥4,962,704,640.38 at the end of the previous year[22] Expenses and Costs - Research and development expenses increased by 65.66% year-on-year, attributed to an increase in personnel and salaries[30] - Sales expenses increased by 63.61% year-on-year, primarily due to new depreciation costs from leased assets[30] - Tax expenses increased by 104.52% year-on-year, correlating with the rise in total profit[31] - Total operating costs amounted to ¥798,566,358.57, up from ¥488,467,737.58, indicating a rise of about 63.5%[42] Other Financial Metrics - The weighted average return on equity for Q1 2023 was 3.54%, an increase from 2.88% in the previous year[22] - The company reported a diluted earnings per share of ¥0.3121 for Q1 2023, which is a 46.46% increase from ¥0.2131 in the same period last year[22] - Other income rose by 43.44% year-on-year, attributed to an increase in government subsidies received[30] Investments and Financing - The total cash inflow from financing activities was ¥1,162,000,000.00, slightly down from ¥1,222,428,080.00 in the previous period[45] - The company absorbed investments amounting to ¥50,000,000.00, compared to ¥312,438,080.00 in the previous period, indicating a decrease of approximately 84%[45] Operational Insights - The company continues to focus on enhancing its operational efficiency and expanding its market presence, although specific strategies were not disclosed in the report[56] - The increase in customer deposits and interbank placements was not detailed in the report, indicating potential growth in customer trust and liquidity[54]
川恒股份:川恒股份业绩说明会、路演活动信息
2023-04-18 10:26
编号:2023-001 投资者关系活动 类别 □特定对象调研 □分析师会议 □媒体采访 √业绩说明会 □新闻发布会 □路演活动 □现场参观 □电话会议 □其他: (请文字说明其他活动内容) 参与单位名称 及人员姓名 川恒股份2022年度业绩说明会采用网络远程方式进行,面向全体投资 者 时间 2023 年 4 月 18 日 15:00-17:00 地点 深圳证券交易所 "互动易平台 "http://irm.cninfo.com.cn"云访谈"栏目 公司接待人员 姓名 主持人:川恒股份 董事长, 总经理:吴海斌 董秘:李建 财务负责人:何永辉 独立董事:李双海 保荐代表人:李迪 投资者关系活动 主要内容介绍 1.目前国内磷酸铁锂市场出现产能过剩,公司在福泉和瓮安新建的磷 酸铁生产线将如何应对产能过剩的情况?是否会减缓或者暂停新建磷 酸铁生产线?谢谢。 答:投资者您好!公司目前已建成一条 10 万吨/年磷酸铁产线,第二条 10 万吨/年的产线尚在建设中,预计 2024 年公司会形成 20 万吨/年的磷 | | 酸铁产能。后续产能的建设将根据实际情况进行。公司磷酸铁产品生 | | --- | --- | | | 产用 ...
川恒股份:举办2022年度业绩说明会的公告
2023-04-10 07:46
| 证券代码:002895 | 证券简称:川恒股份 | 公告编号:2023-033 | | --- | --- | --- | | 转债代码:127043 | 转债简称:川恒转债 | | 贵州川恒化工股份有限公司 举办 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 为促进上市公司规范运作、健康发展,增强上市公司信息透明度,加强与广大 投资者沟通交流,进一步提升投资者关系管理水平,本公司将于 2023 年 4 月 18 日 15:00-17:00 采用网络方式通过深圳证券交易所提供的"互动易"平台举办"川恒股 份 2022 年度业绩说明会"。投资者可登录"互动易"平台(http://irm.cninfo.com.cn) 进入"云访谈"栏目参加本次业绩说明会。 本公司出席本次活动的人员有:公司董事长兼总经理吴海斌先生、董事会秘书 李建先生、董事兼财务负责人何永辉先生、独立董事李双海先生及保荐代表人李迪 先生。 为充分尊重投资者、提升交流的针对性,现就公司本次活动提前向投资者公开 征集问题,广泛听取投资者的意见和建议。投资者可提前登 ...
川恒股份(002895) - 2022 Q4 - 年度财报
2023-03-30 16:00
Financial Performance - The company reported a cash dividend of 7.00 yuan per 10 shares (including tax) for all shareholders, with no bonus shares issued[10]. - The company reported a total loss of 13,335,787.91 yuan in other income and expenses, contrasting with a gain of 24,296,571.54 yuan in 2021[13]. - The company achieved a total revenue of CNY 3.447 billion in 2022, representing a year-on-year growth of 36.26%[71]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, was CNY 771 million, up 124.51% year-on-year, primarily due to increased self-sufficiency in raw materials and rising product prices[71]. - The revenue from the phosphate chemical segment was CNY 2.646 billion, accounting for 76.75% of total revenue, with a year-on-year increase of 45.30%[73]. - The sales of feed-grade dicalcium phosphate reached CNY 1.570 billion, representing 45.55% of total revenue, with a growth of 51.28% year-on-year[73]. - The gross margin for the phosphate chemical segment improved to 44.15%, an increase of 17.09% compared to the previous year[75]. - The company reported a significant increase in the sales price of its products, driven by rising raw material costs and strong demand in the market[75]. Operational Highlights - The company experienced a 44.17% year-on-year decline in the quick ratio, primarily due to increased inventory reserves required for new projects[21]. - The company’s external sales model primarily utilizes direct sales, similar to its internal sales model, with trade settlement methods including FOB and CIF[30]. - The company has established a strong direct sales strategy with major clients, ensuring timely product supply and expanding its distribution network through partnerships with regional distributors[71]. - The company has established long-term supply contracts for sulfur with major suppliers, ensuring stable procurement[124]. - The company has achieved self-sufficiency in phosphate rock supply, only sourcing a small amount of high-grade phosphate rock to meet quality requirements[124]. Market and Product Development - The company is focused on expanding its market presence in the phosphate chemical industry, which is essential for agriculture and various other sectors[27]. - The company is focused on expanding its product offerings, including phosphoric acid and its derivatives, to enhance market presence[33]. - The company has developed specialized ammonium phosphate products for fire extinguishing agents, showcasing its capability in producing high-purity products[40]. - The company is actively developing international markets, particularly in Southeast Asia, South Asia, the Middle East, and Central and South America, with its products being exported to multiple countries[71]. - The global market for feed-grade dicalcium phosphate is expanding, with over 80% of exports used as feed additives for livestock, indicating strong international demand[164]. Research and Development - The company has signed a technical development contract with Beijing University of Science and Technology for research on phosphogypsum filling technology, which is expected to enhance mining recovery rates and reduce costs significantly[41]. - The company has developed low-carbon roadbed and pavement materials from phosphorous tailings, achieving international advanced levels in technology[41]. - The company has established a research center to enhance technological innovation and application, collaborating with universities and research institutions[178]. - The proportion of R&D personnel has increased to 6.64%, with a notable percentage of employees aged 30-40 years[85]. - Research and development expenses increased by 184.40% to ¥110,088,279.15, primarily due to an increase in R&D projects[102]. Environmental and Regulatory Compliance - The company is committed to sustainable practices, as evidenced by its environmental assessments and project approvals aimed at reducing ecological impact[33]. - The company has established a strong regulatory compliance framework with multiple licenses for hazardous chemicals and fertilizers, ensuring operational continuity[36]. - The company received environmental impact assessment approvals for multiple projects, including a 100kt/a food-grade phosphoric acid project approved on October 25, 2022[33]. - The company faces risks related to environmental assessment acceptance during trial production phases, which may require rectifications[33]. - The company is committed to achieving a zero increase in phosphogypsum stockpiling by 2018, with a target to consume phosphogypsum at a growth rate of no less than 10% annually until all stockpiles are eliminated[142]. Financial Management - The total cash inflow from operating activities increased by 49.99% to CNY 3,194,722,820.50, primarily due to increased operating revenue and tax refunds received[89]. - The net cash flow generated from operating activities surged by 575.58% to CNY 543,668,563.86, as the growth rate of cash inflows outpaced that of cash outflows[89]. - The total cash outflow from financing activities rose by 111.87%, mainly due to increased repayments of bank loans, interest payments, and shareholder dividends[90]. - The company's cash and cash equivalents increased by CNY 287,000,918.76, representing a decrease of 58.59% compared to the previous year[89]. - The company has implemented internal controls and risk management measures to mitigate market, liquidity, credit, operational, and legal risks associated with derivative investments[166]. Corporate Governance - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with legal regulations and effective decision-making[186]. - The company has established specialized committees under the board, including a strategic development committee and an audit committee, to oversee various aspects of corporate governance[186]. - The company adheres to legal requirements in convening shareholder meetings, ensuring equal rights for all shareholders, especially minority shareholders[185]. - The company has not encountered any major violations of laws or regulations during the reporting period, reflecting a strong governance framework[187]. - The company is committed to enhancing its talent attraction and retention strategies to improve cohesion and overall performance[200].
川恒股份(002895) - 川恒股份调研活动信息
2022-12-04 09:30
投资者关系活动记录表 证券代码:002895 证券简称:川恒股份 编号:2020-002 | --- | --- | --- | |----------------|-------------------------|------------------------------------------------------| | | | | | 投资者关系活动 | | 特定对象调研 □分析师会议 | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ | 其他 (请文字说明其他活动内容) | | 参与单位名称及 | 华泰证券-庄汀洲 | | | 人员姓名 | | | | 时间 | 2020 年 7 月 28 | 日 | | 地点 | 会议室 | | | 上市公司接待人 | 李建 | | | 员姓名 | | | | 投资者关系活动 | Q1 | :现有湿法磷酸工艺半水法相较于二水法的优势及区别? | | 主要内容介绍 | A1 | :现有磷酸生产工艺主要是热法磷酸技术及湿法磷酸技 | | | | 术,目前,热法磷酸技术主要用于 ...
川恒股份(002895) - 川恒股份调研活动信息
2022-12-04 09:30
投资者关系活动记录表 证券代码:002895 证券简称:川恒股份 贵州川恒化工股份有限公司投资者关系活动记录表 编号:2020-001 | --- | --- | --- | |----------------|---------------------------|----------------------------------------------------| | | | | | 投资者关系活动 | | 特定对象调研 □分析师会议 | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ | 其他 (请文字说明其他活动内容) | | 参与单位名称及 | 申万宏源-马昕晔、方正证券 | - 于宏杰 | | 人员姓名 | | | | 时间 | 2020 年 7 月 21 | 日 | | 地点 | 董事长办公室 | | | 上市公司接待人 | 吴海斌 | | | 员姓名 | | | | 投资者关系活动 | Q1 | ;若其他大型磷化工企业进入公司的细分领域,公司的应 | | 主要内容介绍 | 对措施? | | | | A1 ...
川恒股份(002895) - 川恒股份调研活动信息
2022-11-21 16:10
投资者关系活动记录表 证券代码:002895 证券简称:川恒股份 贵州川恒化工股份有限公司投资者关系活动记录表 编号:2021-001 | --- | --- | --- | --- | --- | --- | |-------------------------|------------------------------------|-----------------------------------------------------------|---------------------------|-----------|--------| | | | | | | | | 投资者关系活动 | 特定对象调研 □分析师会议 | | | | | | 类别 | □媒体采访 □新闻发布会 □路演活动 | □业绩说明会 | | | | | | 现场参观 | | | | | | | □其他 | (请文字说明其他活动内容) | | | | | | | | | | | | 参与单位名称及 人员姓名 | 符健;华泰自营-朱光灵;泰康资产 | 申万宏源-马昕晔、宋涛;汇丰晋信-郑小兵;建信养老-纪石、 - | 曹令、陈 ...
川恒股份(002895) - 川恒股份调研活动信息
2022-11-21 15:40
投资者关系活动记录表 证券代码:002895 证券简称:川恒股份 贵州川恒化工股份有限公司投资者关系活动记录表 编号:2021-002 | --- | --- | --- | --- | --- | --- | --- | |-------------------------|------------------------------|--------------------------------------------------|-------|-------|-------|--------------------------------------------------------| | | | | | | | | | 投资者关系活动 | 特定对象调研 □分析师会议 | | | | | | | 类别 | □媒体采访 | □业绩说明会 | | | | | | | □新闻发布会 □路演活动 | | | | | | | | 现场参观 | | | | | | | | □其他 | (请文字说明其他活动内容) | | | | | | 参与单位名称及 人员姓名 | | 广发证券-邓先河、葛婷婷;中欧基金-王习 ...